Wonderful talk of Beatriz Bellosillo PHD about molecular diagnosis of MPNs at ⁦@sehh_es⁩ Antonio Salar

Colaboración del H Virgen Arrixaca (I) en #Hemato2024 @sehh_es Antonio Salar Área 1 Arrixaca Eva

Colaboración del H Virgen Arrixaca (II) en #Hemato2024 @sehh_es Antonio Salar Área 1 Arrixaca Eva

🎯Biología y tratamiento del linfoma marginal, una patología en aumento #Hemato2024 Antonio Salar ha hecho una gran revisión.👏🏻👏🏻👏🏻

🆕Nueva actualización 2024 de la Guía GELTAMO de práctica clínica para el diagnóstico y tratamiento de los Linfomas T/NK. Ya la puedes consultar y descargar en nuestra web geltamo.com/actividades-ci… @sehh_es SEHH Joven

Happy to participate in a Lymphoma meeting” in Hospital Morales Meseguer. Congratulations for the meeting to the organizers #lymphoma #targeted therapy ⁦Antonio Salar⁩ ⁦⁦Servicio de Hematología. Hosp. U. Morales Meseguer⁩

La 7a edición del curso en diagnóstico y tratamiento del linfoma de GELTAMO ha comenzado hoy en Madrid. Buena participación, excelentes ponencias y exposiciones de casos clínicos.

Marginal zone lymphomas in the Spanish Course of Lymphomas at GELTAMO. Nice to collaborate!! #lymphoma GELTAMO Antonio Salar

Finalizamos nuestras jornadas de #formación en Linfomas. Gracias a todos ponentes y alumnos que han participado en esta edición. Next mayo 2025! #JornadasDeFormación #linfoma GELTAMO SEHH Joven

Proud of thesis defense of Marta Lafuente at UPF. Excellent presentation and up to date in Tumor mutational burden in follicular lymphoma. #lymphoma ⁦Antonio Salar⁩

Excelent morning to start #ASH2024 Ready to attend Saturday sesions ⁦Antonio Salar⁩ #lymphoma #ASH2024

Execellent presentation of Prof L Sehn. Tafasitamab+R2 (InMInd trial) improved PFS in RR follicular lymphoma. An honor to have been involved!! ⁦Antonio Salar⁩ #ASH24

Este jueves se presentan las guías de manejo de biespecificos en linfomas: Webinar Guía manejo de anticuerpos biespecíficos en linfomas no Hodgkin B - 23 de Enero de 2025, 16:00 h Inscripción gratuita en: sedevirtual.geltamo.com/login/signup.p… Antonio Salar #lymphomas  GELTAMO

🔝#CLAVESenLCM Las 10 mejores comunicaciones en #linfoma de células del manto presentadas en el Congreso americano #ASH24, se debaten en este excelente programa moderado por Raul Cordoba, MD, PhD y Ana Marín Niebla. 📹Si te lo perdiste, puedes verlo en nuestro canal de #HemoTube

Delighted to participate at POSS2025 in Al Madinah, and share panel with Dr Andrew Davies and Dr Martin Hutchings. Excellent organization and very interesting talks. #lymphoma ⁦Antonio Salar⁩

💊 Check our poster “Zanubrutinib in R/R Marginal Zone #Lymphoma: Efficacy and Safety of 101 Spanish Patients Treated in the Real-World on Behalf of GELTAMO” at #ICML2025 #18ICML International Conference on Malignant Lymphoma Great effort of all authors! Cohort is still growing ⬆️⬆️⬆️ Ana Muntañola Antonio Salar

🚨 POTENTIAL NEW SOC IN R/R FOLLICULAR #LYMPHOMA!! PFS superiority of Tafasitamab-R2 against Placebo-R2 (inMIND phase 3 trial) 📈 Besides, almost all relapses were CD19+ (thus, subsequent CAR-T access is not compromised) Presented by Dr L Sehn at #ICML2025 #18ICML International Conference on Malignant Lymphoma

Check our poster “Zanubrutinib in R/R Marginal Zone #Lymphoma: Efficacy and Safety of 101 Spanish Patients Treated in the Real-World on Behalf of GELTAMO” at #ICML2025 #18ICML International Conference on Malignant Lymphoma Great effort of all authors! Fernando Martín Moro Ana Muntañola Antonio Salar

Check our poster “Genetic profiling of Marginal Zone Lymphomas ctDNA at diagnosis and during follow-up and prognostic implications” at #ICML2025 #18ICML International Conference on Malignant Lymphoma Great effort of Ramon and all authors! Antonio Salar

Excellent presentation of Emanuele Zucca at Jonh Ultmann Memorial Session at #ICML2025 #18ICML International Conference on Malignant Lymphoma Well done Emanuele!! Antonio Salar